Sofosbuvir/ledipasvir cures nearly all genotype 1 HIV/HCV coinfected patients
All but one
participant treated with a co-formulation of sofosbuvir and ledipasvir (Harvoni) achieved sustained virological
response at 12 weeks post-treatment in a study looking at traditionally hard-to-treat
HIV/HCV coinfected patients, researchers r…